ALKS icon

ALKS

Lightning icon

33.31 USD

+5.86%

Today

+3.98%

1D

Last seen at Tue, 24 Feb 2026 23:43:00 GMT+3

Market is open

Sun

Closed

Mon

4:30 PM ~ 10:59 PM

Tue

4:30 PM ~ 10:59 PM

Wed

4:30 PM ~ 10:59 PM

Thu

4:30 PM ~ 10:59 PM

Fri

4:30 PM ~ 10:59 PM

Sat

Closed

1D
5D
1M
3M
1Y
MAX

Performance

1 Day

+ 3.98 %

1 Week

- 2.19 %

1 Month

- 3.63 %

3 Month

+ 14.69 %

6 Month

+ 11.05 %

1 Year

- 9.36 %

Information

Name

Alkermes plc Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0191%

Overnight Fees Sell

0.0024%

Market Cap

4.68B

Avg Daily Volume

1.80M

52 Week High

36.45 USD

52 Week Low

25.17 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01910%$(0.191)
SELLS0.00240%$0.024

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Top News

Alkermes raises offer for Avadel after Lundbeck bid

finance.yahoo.com

3mo ago

No Image

Avadel (AVDL) Gets 26% Boost on Takeover Bid

finance.yahoo.com

3mo ago

No Image

Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War

finance.yahoo.com

3mo ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.